This article was originally published in The Gray Sheet
A story in the Aug. 27 issue erroneously referred to a patent reform bill (H.R. 1908) as "House-approved" (1"The Gray Sheet" Aug. 27, 2007, p. 3). The bill cleared the House Judiciary Committee, but has not yet been put to a vote on the House floor...
You may also be interested in...
A highly anticipated final 1rule from the U.S. Patent and Trademark Office puts new limits on the number of applications a company can file for any single invention, potentially requiring changes in device manufacturers' patent strategies
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.